List of critical drugs in dermatology: results of a Delphi consensus in France

Drug shortages have increased in recent years, and every country worldwide has been affected. The French Ministry of Health asked various scientific societies to establish a list of ‘critical’ drugs for each specialty. The aim of this list is to enable the public authorities to control the chain of production and guarantee the availability of drugs. We present the list of critical dermatological drugs, which is the result of a strong consensus between all representative entities of the French Society of Dermatology.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2024-11-05
DOI
https://doi.org/10.1093/bjd/ljae427
Citations
1
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
1.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

List of critical drugs in dermatology: results of a Delphi consensus in France

Mahtab Samimi, J Crépin, J.‐F. Séi, J.‐N. Dauendorffer et al.
1 citations
British Journal of Dermatology
Pharmaceutical studies and practices
1.11
article

List of critical drugs in dermatology: results of a Delphi consensus in France

Mahtab Samimi, J Crépin, J.‐F. Séi, J.‐N. Dauendorffer, Eve Pepin, A. Fauconneau, S. Oro, N. Cordel, M.‐A. Richard, T.A. Duong, Henri Adamski, N. Jouan, J Bonnet, G. Quéreux, B. Milpied, S. Barbarot, F. Le Duff, D. Jullien, Caroline Dutriaux, Daniel Toscan du Plantier, Jean-Yves Gourhant, Florence Corgibet, Élisa Cinotti, Marc Reverte, Catherine Pannequin, G. Chaby, C. Lenormand, M. Schöllhammer, M.-H. Jegou, Gwendoline Felker, O. Chosidow, A. Maruani, Davy Beauger, Marie Caucanas, Anne-Céline Davaine, L. Misery, Gaelle Quereux, Frédéric Caux, Élisabeth Roy, A. Petit, Pierre Albaladejo, Cristèle Nicolas, Stéphane Honoré, M. Bataille, Catherine Lok, Pascale Huet, Jean‐Michel Amici, C. Bernier, Isabelle Ollivier, Sandra Ly, D. Staumont, Priscille Carvalho Lallement, Antoinette Petit Roland
article en
1 citations

Abstract

Drug shortages have increased in recent years, and every country worldwide has been affected. The French Ministry of Health asked various scientific societies to establish a list of ‘critical’ drugs for each specialty. The aim of this list is to enable the public authorities to control the chain of production and guarantee the availability of drugs. We present the list of critical dermatological drugs, which is the result of a strong consensus between all representative entities of the French Society of Dermatology.

British Journal of DermatologyVol. 192(2)
IE University (ES), Centre National de la Recherche Scientifique (FR), Inserm (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Délégation Régionale Provence-Alpes-Côte d’Azur et Corse (FR), Immunologie et Nouveaux Concepts en Immunothérapie, Nantes Université (FR)
Openalex Percentile: Top 16%
Pharmaceutical studies and practices
1.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.